Claudia Lefeuvre‐Plesse
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment 7
-
- Cancer survivorship and care 7
- Cancer Treatment and Pharmacology 6
- PARP inhibition in cancer therapy 6
-
- Cancer Genomics and Diagnostics 6
-
- Advanced Breast Cancer Therapies 6
-
- BRCA gene mutations in cancer 4
-
- Childhood Cancer Survivors' Quality of Life 4
Claudia Lefeuvre‐Plesse
33 papers receiving 284 citations
Peers
Comparison fields: 5 of 56
- Reproductive Medicine 77
- Oncology 164
- Cancer Research 43
- Obstetrics and Gynecology 20
- Pulmonary and Respiratory Medicine 59
Countries citing papers authored by Claudia Lefeuvre‐Plesse
This map shows the geographic impact of Claudia Lefeuvre‐Plesse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Lefeuvre‐Plesse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Lefeuvre‐Plesse more than expected).
Fields of papers citing papers by Claudia Lefeuvre‐Plesse
This network shows the impact of papers produced by Claudia Lefeuvre‐Plesse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Lefeuvre‐Plesse. The network helps show where Claudia Lefeuvre‐Plesse may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Claudia Lefeuvre‐Plesse, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 6 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 0 | |
| 7 | 2022 | 1 | |
| 8 | 2022 | 29 | |
| 9 | 2021 | 2 | |
| 10 | 2021 | 7 | |
| 11 | 2020 | 1 | |
| 12 | 2020 | 1 | |
| 13 | 2020 | 12 | |
| 14 | 2020 | 9 | |
| 15 | 2019 | 5 | |
| 16 | 2019 | 14 | |
| 17 | 2017 | 5 | |
| 18 | 2017 | 3 | |
| 19 | 2017 | 18 | |
| 20 | 2009 | 10 |
About Claudia Lefeuvre‐Plesse
Claudia Lefeuvre‐Plesse is a scholar working on Oncology, Reproductive Medicine and Cancer Research, having authored 36 papers that have together received 290 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (7 papers), Cancer survivorship and care (7 papers), Advanced Breast Cancer Therapies (6 papers), Cancer Treatment and Pharmacology (6 papers), Cancer Genomics and Diagnostics (6 papers), PARP inhibition in cancer therapy (6 papers), BRCA gene mutations in cancer (4 papers) and Childhood Cancer Survivors' Quality of Life (4 papers). The work is most often cited by research in Reproductive Medicine (77 citations), Oncology (164 citations) and Cancer Research (43 citations). Claudia Lefeuvre‐Plesse has collaborated with scholars based in France, Spain and Japan. Frequent co-authors include Thibault De La Motte Rouge, Xavier Delbeuck, Florence Pasquier, Jacques Bonneterre, Angélique Brunot, Andrew Kramar, Véronique Quillien, Émilie Le Rhun, Christophe Perrin and Fanny Le Du. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.